Cancel

FOP: Enhancing Diagnosis and Management to Improve Patients’ Quality of Life

Target Audience The educational design of this activity addresses the needs of the primary audience of orthopedists, bone specialists, rheumatologists, pediatric rheumatologists, and genetic counselors, and the secondary audience of PCPs, pediatricians, dermatologists, endocrinologists, occupational therapists, oncologists, general practice NPs and PAs, and specialist NPs and PAs. Program Overview Because fibrodysplasia ossificans progressiva, or FOP, is exceedingly rare, even specialists...
Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC (PQHE), in collaboration with the National Organization for Rare Disorders, Inc. (NORD) and the International Fibrodysplasia Ossificans Progressiva Association (IFOPA) an

Dialogues about FOP: What Patients Wish More Doctors Knew to Enhance Early Recognition and Management

Target Audience The educational design of this activity addresses the needs of the primary audience of PCPs, pediatricians, dermatologists, endocrinologists, occupational therapists, oncologists, general practice NPs and PAs, specialist NPs and PAs, and the secondary audience of orthopedists, bone specialists, rheumatologists, pediatric rheumatologists, genetic counselors, and dentists. Statement of Need/Program Overview Fibrodysplasia ossificans progressiva (FOP) causes abnormal bone for...
Relias LLC

Best of ACTHIV® 2023: Initial ART Regimens for the Newly Diagnosed Patient with HIV

Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module reviews first-line HIV regimens for newly-diagnosed patients with HIV including side effects, discusses rapid ART initiation in newly-diagnosed patients, explores adherence challenges on oral ART and use of long-acting ART, and provides guidance on initial ART if seroconversion occurs on long-acting PrEP. Review first-line HIV regi...
American Academy of CME

Conquering Lab Interpretation (eLearning)

No matter what your area of expertise, no field in medicine spends enough time training you for lab interpretation. Join us as we conquer the interpretation of lab findings to help you gain the clues you need to provide better care to your patients. What we understand, we can then use to set up the plan of the day, to progress the patient towards good outcomes and to predict the next step in the treatment goal. Data collection and understanding are important steps in the development of critica...
MED-ED

Conquering Lab Interpretation (DVD-ROM)

No matter what your area of expertise, no field in medicine spends enough time training you for lab interpretation. Join us as we conquer the interpretation of lab findings to help you gain the clues you need to provide better care to your patients. What we understand, we can then use to set up the plan of the day, to progress the patient towards good outcomes and to predict the next step in the treatment goal. Data collection and understanding are important steps in the development of critica...
MED-ED

Top 10 Questions on Biomarkers in Early Alzheimer’s Disease: Improving Diagnosis and Use of Targeted Therapies

The past several years have seen numerous advances in Alzheimer’s disease (AD) diagnosis and management. Most recently, approval of antiamyloid monoclonal antibodies has revolutionized AD management and has required that patients have amyloid burden verified prior to initiating treatment. Biomarkers, whether obtained from cerebrospinal fluid (CSF) or positron emission tomography (PET) scans, are critical to the early diagnosis of AD and its subsequent management. Plasma biomarkers are an eme...
Integritas Communications

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map